2017 Webinars
Profiling an Oncology Drug with In Vitro Assays and In Vivo Models to Better Understand its Potential Clinical Applications
Metabolomic Approaches in NASH and NAFLD Research and Development
Overcoming Disease Specific Matrix Effects in a Clinical Pharmacokinetic Assay
Pluripotent Stem Cells for Drug Discovery and Toxicity Assessment
Immuno-Oncology: Therapeutic Strategies for Harnessing the Immune System Against Cancer
The Role of Assembly Factors in Ribosome Biogenesis
Accelerate Your Antibody Discovery with High-Throughput Kinetic Screening of Phage Libraries
Expert Perspectives on Liquid Biopsy Clinical Implementations – A Panel Discussion
High Transfection Efficiency of Human Induced Pluripotent Stem Cells and Their Derivatives
Utilization of Preclinical Radiation in Oncology Mouse Models
Challenges for the Development of Immunotherapeutics for Cancer and Role of Fresh Patient Tissue Model in IO Drug Development
Characterization of Drop-In Events using Single-Cell/DEPArray™ Analysis
Advances in High-Throughput Screening of Aggregation, Stability and Viscosity Utilizing Light Scattering in Microwell Plates
Innovation in Translational Rodent Models of Colitis
CANscript™: A Truly Human Translational Platform for Oncology and Immuno-Oncology Drug Discovery and Development
Recent Advances in Transporter Testing Strategies Enable Effective Identification of Potential Drug-Drug Interactions
MonoRabTM Generating Rabbit mAbs with Better Affinity and Specificity for Challenging Targets
Up Your Game in Protein Quantification with Lunatic- Higher Throughput and Concentrations
Targeted Approach to Metabolomics
Animal Modeling of Disease States with a Microbiome Component
Biomarkers for Precision Health: Enabling applications for neurological disease detection and monitoring
Boost Biologics Formulation Screening with Unit and Hunk Analysis
Chemical, Computational, and Instrumental Tools for Challenging Peptide Syntheses
NGS panels - from patient selection to CDx
The Translational Utility of Metabolomics in the Integrative Omics Era
Gaining Executive Buy-in: Key to Project Portfolio Management Success
Dissecting Genetic Heterogeneity in Brain Tumors using Digital Sorting of Single Cells
Accelerating Your Drug Discovery Programme using Fragments: A Blueprint Harnessing 10 Years of Research
Molecular Sample Tracking and Quality Control for Improving Laboratory Workflows
Phospho-Flow Cytometry for the Screening of Intracellular Signaling Events in Cancer Cells and Immune Cells
How to Integrate Clinical, Biomarker, and Other Disparate Data Sources
Better Understand the Activity of Oncology Drugs by Combining the Power of Different Profiling Approaches
A New Humanized Mouse Model of Tumor Growth in Bone for Testing Immunotherapies
Data Analytics Workflows for Faster Biomarker Discovery
Rapid Reagent Screening and Characterization using Automated Nanoliter-scale Immunoassays
Personalized Medicine: The Need for Precise Protein Quantification and Identification
High-throughput Analytics for Formulation and Process Development of Bio- and Nano-therapeutics
Metabolomics Connects the Genome to Phenotype
Improved Monitoring of Tumor Proliferation with a Novel Serum Biomarker – Immunoassay of Thymidine Kinase 1 – TK 210 ELISA
Liquid Biopsy: Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Non-Invasive Tumor Tracker
CRISPR-mediated Gene Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering
CLIA Validation of Digital Cell Sorting Technology and its Ability to Overcome Limitations with Current Oncological Techniques
Advanced Hematology Oncology PDX Tumor Biology Platforms for Drug Advancement
Controlling Pre-Analytical Variables in Liquid Biopsy Assay Development
Evaluation of Liquid Biopsy Methods in SCLC Drug Development